Staging of renal cell carcinoma: Current concepts

Area of Science:

• Urology
• Oncology
• Pathology

Background:

• The tumor, nodes, and metastasis (TNM) staging system is crucial for renal cell carcinoma (RCC) prognosis.
• Accurate staging guides patient counseling, treatment selection, and clinical trial eligibility.
• Recent data raise questions about TNM system revisions and the incorporation of new prognostic factors.

Purpose of the Study:

• To review the current TNM staging system for RCC.
• To explore evolving staging modalities and predictive nomograms.
• To introduce molecular staging as a potential advancement for RCC prognostication.

Main Methods:

• Literature review of TNM staging system components.
• Analysis of current staging modalities and integrated systems.
• Examination of predictive nomograms in RCC.
• Introduction of molecular biomarkers for RCC staging.

Main Results:

• The TNM system is the primary prognostic tool for surgically managed RCC.
• Evolving understanding of RCC biology necessitates exploring new prognostic factors.
• Molecular tumor biomarkers show promise for enhancing prognostic accuracy beyond traditional variables.

Conclusions:

• The TNM staging system for renal cell carcinoma requires re-evaluation.
• Molecular biomarkers are poised to significantly improve RCC prognostic capabilities.
• Future RCC staging may integrate molecular data for more precise patient management.